Sfoglia per Rivista DIABETOLOGIA
GAD and IA-2 antibodies in relation to disease presentation and C-peptide secretion
1996-01-01 Faldetta, Mc; Visalli, N; Cavallo, Mg; Andreani, D; Leslie, Rdg; Hava, M; Pozzilli, P
The GETREM study: New preliminary findings for the clinical remission in IDDM using logistic regression
1997-01-01 Rowne, Pd; Lampeter, E; Deleeuw, I; Iafusco, D; Ionescutirgoviste, C; Kolouskova, S; Linn, T; Ludvigsson, J; Madascy, L; Mrozikiewicz, A; Podar, T; Prisco, M; Vavrinec, J; Vialettes, B; Visalli, N; Yilmaz, T; Pozzilli, P
Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes
2008-01-01 Pronina, E; Petraikina, H; Antsiferov, M; Duchareva, O; Guglielmi, C; Khazrai, M; Pozzilli, P
High and standard dose of nicotinamide in recent onset insulin dependent diabetes (the IMDIAB 6 Study)
1998-01-01 Visalli, N; Ghirlanda, G; Pozzilli, P; Grp, Is.
HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population
2010-01-01 Portuesi, R; Bohm, Bo; Julier, C; Pozzilli, P
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus
2013-01-01 Strollo, R; Rizzo, P; Spoletini, M; Landy, R; Hughes, C; Ponchel, F; Napoli, N; Palermo, A; Buzzetti, R; Pozzilli, P; Nissim, A
HLA-MATCHED CONTROL SUBJECTS ARE ESSENTIAL IN STUDIES OF SUSCEPTIBILITY TO IDDM - REPLY
1995-01-01 Pozzilli, P; Buzzetti, R; Bottazzo, G; Tosi, R
HUMAN INSULINOMA CELL-LINE EXPRESSING CONSTITUTIVE BETA-CELL GENES
1995-01-01 Baroni, Mg; Gragnoli, C; Cavallo, Mg; Latini, L; Valente, L; Andreani, D; Pozzilli, P
Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce autoimmune insulitis?
1997-01-01 Pozzilli, P; Leslie, Rdg
HYPOMAGNESEMIA IN IDDM PATIENTS WITH MICROALBUMINURIA AND CLINICAL PROTEINURIA - REPLY
1994-01-01 Pozzilli, P
Identification of type 1 diabetic patients with insulitis at diagnosis by Tc-99m-IL2 scintigraphy
1998-01-01 Signore, A; Chianelli, M; Visalli, N; Barone, R; Annovazzi, A; Di Leve, G; Parisella, Mg; Pozzilli, P; Grp, Is
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes
2006-01-01 Vadacca, M; Valorani, G; Humphreys, Re; Kallinteris, N; Valente, L; Pozzilli, P; Group, I
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes.
2007-01-01 Vadacca, M; Valorani, G; Humphreys, R; Kallinteris, N; Valente, L; D'Agostino, G; Pozzilli, P; Grp, I.
IMMUNOTHERAPY IN PRE-TYPE-1 DIABETES-MELLITUS
1990-01-01 Bach, Jf; Dupre, J; Eisenbarth, Gs; Harrison, Lc; Maclaren, Nk; Nerup, J; Pozzilli, P
IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION
1995-01-01 Signore, A; Chianelli, M; Picarelli, A; Ferretti, E; Greco, M; Multari, M; Demattia, G; Pozzilli, P
IN-VIVO IMAGING OF ACTIVATED LYMPHOCYTES IN THE PANCREAS OF NEWLY-DIAGNOSED DIABETIC-PATIENTS
1993-01-01 Signore, A; Chianelli, M; Ferretti, E; Mather, Sj; Gale, Eam; Pozzilli, P
Incomplete Freund's adjuvant protects NOD mice from type 1 diabetes
1998-01-01 Beales, Pe; Liddi, R; Matta, G; Webb, Gp; Pozzilli, P
Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II
2005-01-01 Spoletini, M; Petrone, A; Galgani, A; Bassotti, G; Guglielmi, C; Picardi, A; Manfrini, S; Imdiab, G; Pozzilli, P; Buzzetti, R
Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse
2008-01-01 Khoo, Cp; Hill, N; Valorani, Mg; Signore, A; Pozzilli, P
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project).
2003-01-01 Valdes, A; Buzzetti, R; Galgani, A; Visalli, N; Montemari, Al; Bosi, E; Meschi, F; Lorini, R; Minicucci, L; Cristaldi, A; Locatelli, M; Bottazzo, Gf; Pozzilli, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
GAD and IA-2 antibodies in relation to disease presentation and C-peptide secretion | 1-gen-1996 | Faldetta, Mc; Visalli, N; Cavallo, Mg; Andreani, D; Leslie, Rdg; Hava, M; Pozzilli, P | |
The GETREM study: New preliminary findings for the clinical remission in IDDM using logistic regression | 1-gen-1997 | Rowne, Pd; Lampeter, E; Deleeuw, I; Iafusco, D; Ionescutirgoviste, C; Kolouskova, S; Linn, T; Ludvigsson, J; Madascy, L; Mrozikiewicz, A; Podar, T; Prisco, M; Vavrinec, J; Vialettes, B; Visalli, N; Yilmaz, T; Pozzilli, P | |
Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes | 1-gen-2008 | Pronina, E; Petraikina, H; Antsiferov, M; Duchareva, O; Guglielmi, C; Khazrai, M; Pozzilli, P | |
High and standard dose of nicotinamide in recent onset insulin dependent diabetes (the IMDIAB 6 Study) | 1-gen-1998 | Visalli, N; Ghirlanda, G; Pozzilli, P; Grp, Is. | |
HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population | 1-gen-2010 | Portuesi, R; Bohm, Bo; Julier, C; Pozzilli, P | |
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus | 1-gen-2013 | Strollo, R; Rizzo, P; Spoletini, M; Landy, R; Hughes, C; Ponchel, F; Napoli, N; Palermo, A; Buzzetti, R; Pozzilli, P; Nissim, A | |
HLA-MATCHED CONTROL SUBJECTS ARE ESSENTIAL IN STUDIES OF SUSCEPTIBILITY TO IDDM - REPLY | 1-gen-1995 | Pozzilli, P; Buzzetti, R; Bottazzo, G; Tosi, R | |
HUMAN INSULINOMA CELL-LINE EXPRESSING CONSTITUTIVE BETA-CELL GENES | 1-gen-1995 | Baroni, Mg; Gragnoli, C; Cavallo, Mg; Latini, L; Valente, L; Andreani, D; Pozzilli, P | |
Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce autoimmune insulitis? | 1-gen-1997 | Pozzilli, P; Leslie, Rdg | |
HYPOMAGNESEMIA IN IDDM PATIENTS WITH MICROALBUMINURIA AND CLINICAL PROTEINURIA - REPLY | 1-gen-1994 | Pozzilli, P | |
Identification of type 1 diabetic patients with insulitis at diagnosis by Tc-99m-IL2 scintigraphy | 1-gen-1998 | Signore, A; Chianelli, M; Visalli, N; Barone, R; Annovazzi, A; Di Leve, G; Parisella, Mg; Pozzilli, P; Grp, Is | |
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes | 1-gen-2006 | Vadacca, M; Valorani, G; Humphreys, Re; Kallinteris, N; Valente, L; Pozzilli, P; Group, I | |
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. | 1-gen-2007 | Vadacca, M; Valorani, G; Humphreys, R; Kallinteris, N; Valente, L; D'Agostino, G; Pozzilli, P; Grp, I. | |
IMMUNOTHERAPY IN PRE-TYPE-1 DIABETES-MELLITUS | 1-gen-1990 | Bach, Jf; Dupre, J; Eisenbarth, Gs; Harrison, Lc; Maclaren, Nk; Nerup, J; Pozzilli, P | |
IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION | 1-gen-1995 | Signore, A; Chianelli, M; Picarelli, A; Ferretti, E; Greco, M; Multari, M; Demattia, G; Pozzilli, P | |
IN-VIVO IMAGING OF ACTIVATED LYMPHOCYTES IN THE PANCREAS OF NEWLY-DIAGNOSED DIABETIC-PATIENTS | 1-gen-1993 | Signore, A; Chianelli, M; Ferretti, E; Mather, Sj; Gale, Eam; Pozzilli, P | |
Incomplete Freund's adjuvant protects NOD mice from type 1 diabetes | 1-gen-1998 | Beales, Pe; Liddi, R; Matta, G; Webb, Gp; Pozzilli, P | |
Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II | 1-gen-2005 | Spoletini, M; Petrone, A; Galgani, A; Bassotti, G; Guglielmi, C; Picardi, A; Manfrini, S; Imdiab, G; Pozzilli, P; Buzzetti, R | |
Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse | 1-gen-2008 | Khoo, Cp; Hill, N; Valorani, Mg; Signore, A; Pozzilli, P | |
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). | 1-gen-2003 | Valdes, A; Buzzetti, R; Galgani, A; Visalli, N; Montemari, Al; Bosi, E; Meschi, F; Lorini, R; Minicucci, L; Cristaldi, A; Locatelli, M; Bottazzo, Gf; Pozzilli, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile